Multidisciplinary teams key to best outcomes for patients with hepatocellular carcinoma

Associate Professor John Lubel

A new consensus statement produced by the Gastroenterological Society of Australia (GESA) Liver Faculty on the management of hepatocellular carcinoma (HCC) will ultimately lead to better outcomes for Australian patients, according to the authors, published 14 Dec 2020 in the Medical Journal of Australia.

HCC is a leading cause of cancer deaths both globally and in Australia. Surveillance for HCC in at-risk populations allows diagnosis at an early stage, when potentially curable. However, most Australians diagnosed with HCC die of the cancer or of liver disease.